Preliminary evaluation of a 3H imidazoquinoline library as dual TLR7/TLR8 antagonists

Nikunj M. Shukla, Subbalakshmi S. Malladi, Victor Day, Sunil A. David

Research output: Contribution to journalArticlepeer-review

40 Scopus citations


Toll-like receptors (TLR) -7 and -8 are thought to play an important role in immune activation processes underlying the pathophysiology of HIV and several clinically important autoimmune diseases. Based on our earlier findings of TLR7-antagonistic activity in a 3H imidazoquinoline, we sought to examine a pilot library of 3H imidazoquinolines for dual TLR7/8 antagonists, since they remain a poorly explored chemotype. 2D-NOE experiments were employed to unequivocally characterize the compounds. A quinolinium compound 12, bearing p-methoxybenzyl substituents on N3 and N5 positions was identified as a lead. Compound 12 was found to inhibit both TLR7 and TLR8 at low micromolar concentrations. Our preliminary results suggest that alkylation with electron-rich substituents on the quinoline N5, or conversely, elimination of the fixed charge of the resultant quaternary amine on the quinolinium may yield more active compounds.

Original languageEnglish (US)
Pages (from-to)3801-3811
Number of pages11
JournalBioorganic and Medicinal Chemistry
Issue number12
StatePublished - Jun 15 2011
Externally publishedYes

Bibliographical note

Copyright 2012 Elsevier B.V., All rights reserved.


  • Autoimmune diseases
  • HIV
  • Imidazoquinoline
  • TLR7
  • TLR8
  • Toll-like receptor


Dive into the research topics of 'Preliminary evaluation of a 3H imidazoquinoline library as dual TLR7/TLR8 antagonists'. Together they form a unique fingerprint.

Cite this